Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma
Aim: We report the value of sentinel lymph node (SLN) biopsy and fluorodeoxyglucose-positron emission tomography (FDG-PET) in relation to SLN biopsy in staging primary cutaneous melanoma. Methods: Fifty-five patients with primary cutaneous melanoma >1.0 mm. Breslow thickness and no palpable regio...
Gespeichert in:
| Veröffentlicht in: | European journal of surgical oncology 2003-10, Vol.29 (8), p.662-664 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 664 |
|---|---|
| container_issue | 8 |
| container_start_page | 662 |
| container_title | European journal of surgical oncology |
| container_volume | 29 |
| creator | Havenga, K Cobben, D.C.P Oyen, W.J.G Nienhuijs, S Hoekstra, H.J Ruers, T.J.M Wobbes, Th |
| description | Aim: We report the value of sentinel lymph node (SLN) biopsy and fluorodeoxyglucose-positron emission tomography (FDG-PET) in relation to SLN biopsy in staging primary cutaneous melanoma.
Methods: Fifty-five patients with primary cutaneous melanoma >1.0 mm. Breslow thickness and no palpable regional lymph nodes underwent a FDG-PET scan before SLN biopsy.
Results: SLN's were retrieved in 53 patients. Melanoma metastases were found in the SLN of 13 patients. FDG-PET detected the lymph node metastases in two of the 13 patients with SLN metastases. In five patients FDG accumulation was recorded in a regional lymph node basin, while no tumour positive SLN was found. In eight patients FDG-PET showed increased activity at a site of possible distant metastasis. Metastatic disease was confirmed in one patient. No explanation for the positive FDG-PET result could be found in five cases.
Conclusion: FDG-PET should not be considered in this group. SLN biopsy reveals regional metastases that are too small to be detected by FDG-PET. The prevalence of distant metastases is too small to justify routine use of FDG-PET. |
| doi_str_mv | 10.1016/S0748-7983(03)00147-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75718724</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0748798303001471</els_id><sourcerecordid>75718724</sourcerecordid><originalsourceid>FETCH-LOGICAL-c323t-90295b6d85c8bee587ec771c8409995f4a03867cd88acb05986cd16ce09bfc1a3</originalsourceid><addsrcrecordid>eNqFkMGO1SAUhonRONfRR9Cw0eiiymlLgdXETBw1mcSFuiaUnt7BUKhAjX17e72NszQhgcX3n_PzEfIc2Ftg0L37ykQrK6Fk85o1bxiDVlTwgByAN3VVAxcPyeEfckGe5PyDMaYaoR6TC2g5QAftgZQbv8QUB4y_16NfbMxYzTG7kmKgOLmc3fYocYrHZOa7lZow0IyhuICe-nWa72jY4rR3cc4rdYHmYo4uHOmc3GTSSu1STMC4ZDqhNyFO5il5NBqf8dl-X5LvNx--XX-qbr98_Hz9_rayTd2USrFa8b4bJLeyR-RSoBUCrGyZUoqPrWGN7IQdpDS2Z1zJzg7QWWSqHy2Y5pK8Os-dU_y5YC56-5BF7899tOACpKjbDeRn0KaYc8JR7-U1MH3Srf_q1ieXmm3npFvDlnuxL1j6CYf71O53A17ugMnW-DGZYF2-53gNHe9O3NWZw03HL4dJZ-swWBxcQlv0EN1_qvwB0NKfwQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75718724</pqid></control><display><type>article</type><title>Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Havenga, K ; Cobben, D.C.P ; Oyen, W.J.G ; Nienhuijs, S ; Hoekstra, H.J ; Ruers, T.J.M ; Wobbes, Th</creator><creatorcontrib>Havenga, K ; Cobben, D.C.P ; Oyen, W.J.G ; Nienhuijs, S ; Hoekstra, H.J ; Ruers, T.J.M ; Wobbes, Th</creatorcontrib><description>Aim: We report the value of sentinel lymph node (SLN) biopsy and fluorodeoxyglucose-positron emission tomography (FDG-PET) in relation to SLN biopsy in staging primary cutaneous melanoma.
Methods: Fifty-five patients with primary cutaneous melanoma >1.0 mm. Breslow thickness and no palpable regional lymph nodes underwent a FDG-PET scan before SLN biopsy.
Results: SLN's were retrieved in 53 patients. Melanoma metastases were found in the SLN of 13 patients. FDG-PET detected the lymph node metastases in two of the 13 patients with SLN metastases. In five patients FDG accumulation was recorded in a regional lymph node basin, while no tumour positive SLN was found. In eight patients FDG-PET showed increased activity at a site of possible distant metastasis. Metastatic disease was confirmed in one patient. No explanation for the positive FDG-PET result could be found in five cases.
Conclusion: FDG-PET should not be considered in this group. SLN biopsy reveals regional metastases that are too small to be detected by FDG-PET. The prevalence of distant metastases is too small to justify routine use of FDG-PET.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1016/S0748-7983(03)00147-1</identifier><identifier>PMID: 14511614</identifier><identifier>CODEN: EJSOE7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Dermatology ; Female ; Fluorodeoxyglucose F18 ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Lymphatic Metastasis ; Male ; Medical sciences ; melanoma ; Melanoma - diagnostic imaging ; Melanoma - surgery ; Middle Aged ; Miscellaneous. Technology ; Neoplasm Staging - methods ; positron emission tomography ; Predictive Value of Tests ; Radionuclide investigations ; Radiopharmaceuticals ; Sentinel Lymph Node Biopsy ; Skin Neoplasms - diagnostic imaging ; Skin Neoplasms - surgery ; Tomography, Emission-Computed - methods ; Tumors of the skin and soft tissue. Premalignant lesions</subject><ispartof>European journal of surgical oncology, 2003-10, Vol.29 (8), p.662-664</ispartof><rights>2003 Elsevier Ltd</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c323t-90295b6d85c8bee587ec771c8409995f4a03867cd88acb05986cd16ce09bfc1a3</citedby><cites>FETCH-LOGICAL-c323t-90295b6d85c8bee587ec771c8409995f4a03867cd88acb05986cd16ce09bfc1a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0748-7983(03)00147-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27926,27927,45997</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15216564$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14511614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Havenga, K</creatorcontrib><creatorcontrib>Cobben, D.C.P</creatorcontrib><creatorcontrib>Oyen, W.J.G</creatorcontrib><creatorcontrib>Nienhuijs, S</creatorcontrib><creatorcontrib>Hoekstra, H.J</creatorcontrib><creatorcontrib>Ruers, T.J.M</creatorcontrib><creatorcontrib>Wobbes, Th</creatorcontrib><title>Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Aim: We report the value of sentinel lymph node (SLN) biopsy and fluorodeoxyglucose-positron emission tomography (FDG-PET) in relation to SLN biopsy in staging primary cutaneous melanoma.
Methods: Fifty-five patients with primary cutaneous melanoma >1.0 mm. Breslow thickness and no palpable regional lymph nodes underwent a FDG-PET scan before SLN biopsy.
Results: SLN's were retrieved in 53 patients. Melanoma metastases were found in the SLN of 13 patients. FDG-PET detected the lymph node metastases in two of the 13 patients with SLN metastases. In five patients FDG accumulation was recorded in a regional lymph node basin, while no tumour positive SLN was found. In eight patients FDG-PET showed increased activity at a site of possible distant metastasis. Metastatic disease was confirmed in one patient. No explanation for the positive FDG-PET result could be found in five cases.
Conclusion: FDG-PET should not be considered in this group. SLN biopsy reveals regional metastases that are too small to be detected by FDG-PET. The prevalence of distant metastases is too small to justify routine use of FDG-PET.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Dermatology</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>melanoma</subject><subject>Melanoma - diagnostic imaging</subject><subject>Melanoma - surgery</subject><subject>Middle Aged</subject><subject>Miscellaneous. Technology</subject><subject>Neoplasm Staging - methods</subject><subject>positron emission tomography</subject><subject>Predictive Value of Tests</subject><subject>Radionuclide investigations</subject><subject>Radiopharmaceuticals</subject><subject>Sentinel Lymph Node Biopsy</subject><subject>Skin Neoplasms - diagnostic imaging</subject><subject>Skin Neoplasms - surgery</subject><subject>Tomography, Emission-Computed - methods</subject><subject>Tumors of the skin and soft tissue. Premalignant lesions</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMGO1SAUhonRONfRR9Cw0eiiymlLgdXETBw1mcSFuiaUnt7BUKhAjX17e72NszQhgcX3n_PzEfIc2Ftg0L37ykQrK6Fk85o1bxiDVlTwgByAN3VVAxcPyeEfckGe5PyDMaYaoR6TC2g5QAftgZQbv8QUB4y_16NfbMxYzTG7kmKgOLmc3fYocYrHZOa7lZow0IyhuICe-nWa72jY4rR3cc4rdYHmYo4uHOmc3GTSSu1STMC4ZDqhNyFO5il5NBqf8dl-X5LvNx--XX-qbr98_Hz9_rayTd2USrFa8b4bJLeyR-RSoBUCrGyZUoqPrWGN7IQdpDS2Z1zJzg7QWWSqHy2Y5pK8Os-dU_y5YC56-5BF7899tOACpKjbDeRn0KaYc8JR7-U1MH3Srf_q1ieXmm3npFvDlnuxL1j6CYf71O53A17ugMnW-DGZYF2-53gNHe9O3NWZw03HL4dJZ-swWBxcQlv0EN1_qvwB0NKfwQ</recordid><startdate>20031001</startdate><enddate>20031001</enddate><creator>Havenga, K</creator><creator>Cobben, D.C.P</creator><creator>Oyen, W.J.G</creator><creator>Nienhuijs, S</creator><creator>Hoekstra, H.J</creator><creator>Ruers, T.J.M</creator><creator>Wobbes, Th</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20031001</creationdate><title>Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma</title><author>Havenga, K ; Cobben, D.C.P ; Oyen, W.J.G ; Nienhuijs, S ; Hoekstra, H.J ; Ruers, T.J.M ; Wobbes, Th</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c323t-90295b6d85c8bee587ec771c8409995f4a03867cd88acb05986cd16ce09bfc1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Dermatology</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>melanoma</topic><topic>Melanoma - diagnostic imaging</topic><topic>Melanoma - surgery</topic><topic>Middle Aged</topic><topic>Miscellaneous. Technology</topic><topic>Neoplasm Staging - methods</topic><topic>positron emission tomography</topic><topic>Predictive Value of Tests</topic><topic>Radionuclide investigations</topic><topic>Radiopharmaceuticals</topic><topic>Sentinel Lymph Node Biopsy</topic><topic>Skin Neoplasms - diagnostic imaging</topic><topic>Skin Neoplasms - surgery</topic><topic>Tomography, Emission-Computed - methods</topic><topic>Tumors of the skin and soft tissue. Premalignant lesions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Havenga, K</creatorcontrib><creatorcontrib>Cobben, D.C.P</creatorcontrib><creatorcontrib>Oyen, W.J.G</creatorcontrib><creatorcontrib>Nienhuijs, S</creatorcontrib><creatorcontrib>Hoekstra, H.J</creatorcontrib><creatorcontrib>Ruers, T.J.M</creatorcontrib><creatorcontrib>Wobbes, Th</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Havenga, K</au><au>Cobben, D.C.P</au><au>Oyen, W.J.G</au><au>Nienhuijs, S</au><au>Hoekstra, H.J</au><au>Ruers, T.J.M</au><au>Wobbes, Th</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2003-10-01</date><risdate>2003</risdate><volume>29</volume><issue>8</issue><spage>662</spage><epage>664</epage><pages>662-664</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><coden>EJSOE7</coden><abstract>Aim: We report the value of sentinel lymph node (SLN) biopsy and fluorodeoxyglucose-positron emission tomography (FDG-PET) in relation to SLN biopsy in staging primary cutaneous melanoma.
Methods: Fifty-five patients with primary cutaneous melanoma >1.0 mm. Breslow thickness and no palpable regional lymph nodes underwent a FDG-PET scan before SLN biopsy.
Results: SLN's were retrieved in 53 patients. Melanoma metastases were found in the SLN of 13 patients. FDG-PET detected the lymph node metastases in two of the 13 patients with SLN metastases. In five patients FDG accumulation was recorded in a regional lymph node basin, while no tumour positive SLN was found. In eight patients FDG-PET showed increased activity at a site of possible distant metastasis. Metastatic disease was confirmed in one patient. No explanation for the positive FDG-PET result could be found in five cases.
Conclusion: FDG-PET should not be considered in this group. SLN biopsy reveals regional metastases that are too small to be detected by FDG-PET. The prevalence of distant metastases is too small to justify routine use of FDG-PET.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>14511614</pmid><doi>10.1016/S0748-7983(03)00147-1</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0748-7983 |
| ispartof | European journal of surgical oncology, 2003-10, Vol.29 (8), p.662-664 |
| issn | 0748-7983 1532-2157 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_75718724 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adolescent Adult Aged Biological and medical sciences Dermatology Female Fluorodeoxyglucose F18 Humans Investigative techniques, diagnostic techniques (general aspects) Lymphatic Metastasis Male Medical sciences melanoma Melanoma - diagnostic imaging Melanoma - surgery Middle Aged Miscellaneous. Technology Neoplasm Staging - methods positron emission tomography Predictive Value of Tests Radionuclide investigations Radiopharmaceuticals Sentinel Lymph Node Biopsy Skin Neoplasms - diagnostic imaging Skin Neoplasms - surgery Tomography, Emission-Computed - methods Tumors of the skin and soft tissue. Premalignant lesions |
| title | Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T05%3A50%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fluorodeoxyglucose-positron%20emission%20tomography%20and%20sentinel%20lymph%20node%20biopsy%20in%20staging%20primary%20cutaneous%20melanoma&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Havenga,%20K&rft.date=2003-10-01&rft.volume=29&rft.issue=8&rft.spage=662&rft.epage=664&rft.pages=662-664&rft.issn=0748-7983&rft.eissn=1532-2157&rft.coden=EJSOE7&rft_id=info:doi/10.1016/S0748-7983(03)00147-1&rft_dat=%3Cproquest_cross%3E75718724%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75718724&rft_id=info:pmid/14511614&rft_els_id=S0748798303001471&rfr_iscdi=true |